Cargando…
P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
Autores principales: | Tucci, Francesca, Consiglieri, Giulia, Filisetti, Chiara, De Pellegrin, Maurizio, Mellone, Renata, Fumagalli, Francesca, Darin, Silvia, Sarzana, Marina, Scarparo, Stefano, Ciotti, Francesca, Silvani, Paolo, Baldoli, Cristina, Pontesilli, Silvia, Parini, Rossella, la Marca, Giancarlo, Ciceri, Fabio, Naldini, Luigi, Aiuti, Alessandro, Gentner, Bernhard, Ester Bernardo, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430690/ http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59 |
Ejemplares similares
-
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
por: Calbi, Valeria, et al.
Publicado: (2018) -
Preserving Ambulation in a Gene Therapy-Treated Girl Affected by Metachromatic Leukodystrophy: A Case Report
por: Faccioli, Silvia, et al.
Publicado: (2023) -
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
por: Canarutto, Daniele, et al.
Publicado: (2021) -
Open issues in Mucopolysaccharidosis type I-Hurler
por: Parini, Rossella, et al.
Publicado: (2017) -
A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders
por: Tucci, Francesca, et al.
Publicado: (2022)